Jiangsu Hengrui Medicine (600276.SS) Free Cash Flow
Market Cap: $293.53B
Avg Volume: 35.56M
Industry: Drug Manufacturers - General
Sector: Healthcare
What is Jiangsu Hengrui Medicine 's Free Cash Flow?
- Jiangsu Hengrui Medicine 's annual free cash flow as of FY 2023 is $6.16B.
- Jiangsu Hengrui Medicine 's quarterly free cash flow as of QQ3 2024 is $1.00B.
What is Free Cash Flow?
Free cash flow (FCF) is a measure of financial performance calculated as operating cash flow minus capital expenditures. It represents the cash that a company generates after accounting for cash outflows to support operations and maintain its capital assets. FCF is important because it allows a company to pursue opportunities that enhance shareholder value.
How is Free Cash Flow calculated?
The formula for free cash flow is:
Free Cash Flow = Operating Cash Flow - Capital Expenditures
This metric helps investors understand the company's ability to generate cash and its potential to pay dividends or expand.
Related Metrics
Other important metrics to assess Jiangsu Hengrui Medicine 's free cash flow financial health include:
- Free Cash Flow Growth - the rate at which a company's free cash flow is growing:
- Annual Growth: 947.40%
- Free Cash Flow Per Share - free cash flow divided by the number of shares outstanding:
- Annual: $0.97
- Free Cash Flow Yield - free cash flow divided by the market capitalization:
- Annual: 2.15%
These metrics provide insights into Jiangsu Hengrui Medicine 's financial health and its ability to generate cash. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual Free Cash Flow
$6.16B
Quarterly Free Cash Flow
$1.00B
Historical Annual Free Cash Flow
Historical Quarterly Free Cash Flow
Annual Free Cash Flow Growth
Annual Free Cash Flow Per Share
Jiangsu Hengrui Medicine Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2023.
| Year | Free Cash Flow | Free Cash Flow Growth | Free Cash Flow Per Share | Free Cash Flow Yield |
|---|---|---|---|---|
| 2023 | $6.16B | 947.40% | $0.97 | 2.15% |
| 2022 | $-726.91M | -128.46% | $-0.11 | -0.30% |
| 2021 | $2.55B | -11.24% | $0.40 | 0.79% |
| 2020 | $2.88B | -11.61% | $0.45 | 0.49% |
| 2019 | $3.26B | 45.00% | $0.51 | 0.85% |
| 2018 | $2.25B | 3.60% | $0.35 | 1.15% |
| 2017 | $2.17B | 46.26% | $0.34 | 1.35% |
| 2016 | $1.48B | -21.32% | $0.23 | 1.67% |
| 2015 | $1.88B | 47.61% | $0.30 | 2.35% |
| 2014 | $1.28B | 39.94% | $0.20 | 3.27% |
Related Metrics
Explore detailed financial metrics and analysis for 600276.SS.